# Trade Mark Journal No.2026/029 17 July 2026

## UK00004413659 9 July 2026 (1,5,42)

CalixRAD

Class 1
  Reagents for use in the development of monoclonal antibodies [other than for medical or veterinary purposes]; In-vivo radiological contrast substances for scientific use; Diagnostic reagents for in-vitro use [other than medical]; In-vivo diagnostic reagents for scientific use; Monoclonal antibody reagents, other than for medical use; Chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; Radiological contrast substances, other than for medical purposes; Chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Gadolinium; Gallium compounds; Diagnostic scanning agents for in-vivo use [other than medical]; Radioactive preparations for laboratory purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Reagents for use with analyzers [other than for medical or veterinary purposes]; Reagents for in-vitro laboratory use [other than for medical or veterinary purposes]; Chemical preparations for use in the manufacture of pharmaceuticals; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Reagents (Chemical -) other than for medical or veterinary purposes; Immunoassay reagents, other than for medical use; Antibody reagents for scientific purposes; Radiochemical products for scientific purposes; Chemical substances for analysis in laboratories [other than for medical or veterinary purposes]; Chemical reagents for use in biotechnology, other than for medical or veterinary use.
Class 5
  Radiopharmaceutical products; Diagnostic radiopharmaceutical preparations; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for use in oncology; Injectable pharmaceuticals; Pharmaceutical preparations for the treatment of tumours; Clinical diagnostic reagents; Radioactive substances for medical purposes; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations and substances; Pharmaceuticals; Diagnostic biomarker reagents for medical purposes; Clinical medical reagents; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations and substances for the prevention of cancer; Medical diagnostic reagents; Radio-isotope markers for therapeutic or diagnostic use; Pharmaceutical products for the treatment of bone diseases; Cardiovascular pharmaceuticals; Diagnostic reagents for medicinal use; Pharmaceutical drugs; Antitumor drugs; Synthetic peptides for pharmaceutical purposes.
Class 42
  Development of pharmaceutical preparations and medicines; Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines.

ChemKAS Pharmaceutics Limited